💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
Clinical profile of cardiomyopathy
1. Dr. Sachin Adukia, Post graduate student, Bharati hospital and research center, Pune.
2. An 18 year old, previously healthy, primigravida of 26
weeks gestation.
Admitted late night with complaints of
mild fronto-temporal throbbing headache
scanty clear vomit x 2 days
low grade fever.
Early morning she had
an episode of generalized tonic clonic seizure lasting 2 to 3 mins
followed by loss of consciousness.
3. Physical examination
Her blood pressure remained 170/110 mm Hg inspite of
giving nifedipine and alpha-methyldopa.
Both pupils were equal, reacting to light; bilateral
plantars extensor.
Mild Pallor +
Other systems were normal.
4. Initial diagnosis and Investigations
Result
Negative ANA Test
Normal venogram but MRI s/o
PRES
Investigations ordered
Antinuclear antibody test MRI brain with venogram
Initial differential diagnosis
Systemic lupus erythematosus Central venous sinus thrombosis
8. Other investigations (2)
Urine examination:
Dark red turbid urine
RBC’s plenty s/o haemoglobinuria,
sugar and protein absent.
9. Other investigations (3)
USG abdomen:
Single live intra-uterine pregnancy- 25 weeks 6 days with
oligohydramnios
asymmetric intra uterine growth retardation.
Medical termination of pregnancy done;
procedure uneventful
14. Treatment: Pre- and Post-diagnosis
Pre
• IV Antibiotics and IV Steroids
• Packed red cells and Platelets
• Supportive treatment
Post
• Plasmapheresis
• Fresh frozen plasma
• Above treatment continued
15. Clinical course and Outcome
She underwent a total of 5 sittings of plasmapheresis
(therapeutic plasma exchange) with fresh frozen plasma (FFP).
She continued to receive packed red cells and platelet
transfusions.
4 FFPs were transfused daily till platelet and LDH
normalization.
Urine output improved as did the RFT’s
No repeat convulsions, neurologically improved; weaned off
ventilatory support completely.
Once stable, she was discharged on day 12.
17. Thrombotic thrombocytopenic purpura in pregnancy
Classified as idiopathic, secondary (65%) and familial
TTP has a strong relation to pregnancy
seen as commonly as 1 in 25,000 pregnancies.
Reason
association of pregnancy with increasing concentrations of
procoagulant factors
decreasing fibrinolytic activity
loss of endothelial cell thrombomodulin
decreasing activity of ADAMTS-13.
All of these abnormalities worsen through the course of
pregnancy until delivery and immediately post-partum.
18. Pregnancy-associated microangiopathies
Entity MAHA Thrombocytopenia Coagulopathy High BP Abdominal
symptoms
Renal
Impairment
Neurological
symptoms
Pre
Eclampsia
+ + +/- +++ +/- +/- ++
HELLP + ++ +/- + +++ + +/-
TTP ++ +++ - +/- + ++ +++
HUS + ++ +/- ++ + +++ +/-
SLE + + +/- + +/- ++ +
Delivery generally leads to a rapid resolution of preeclampsia and HELLP
syndrome, however if no improvement is seen after 48 to 72 hours of
delivery, possibility of thrombotic microangiopathies should be considered.
19. Posterior reversible encephalopathy syndrome in TTP
Posterior reversible encephalopathy syndrome (PRES)
the predominant brain neuroimaging abnormality in TTP.
no association between degree of hypertension, hematocrit or
platelet count, D dimer, fibrinogen, LDH, or total bilirubin levels
and PRES.
The presentation:
Benign- headache, vomiting
Severe- confusion, seizures, visual abnormalities and motor signs.
is completely reversible if the underlying cause is treated early
However, PRES in TTP is associated with worse renal
function.
20. Mortality in TTP in pregnancy
• widespread microvascular thromboses
• multiple organ dysfunction
Maternal
Mortality
• Placental infarction leads to fetal
intra-uterine growth retardation
and/or mortality
Fetal
mortality
22. Plasmapheresis: a boon of modern science
•Plasmapheresis
(therapeutic plasma
exchange- TPE) has
reduced mortality
rates, from over
90% to 10–20%.
•Earlier initiation of
TPE correlates with
a better prognosis.
• TPE allows
removal of
autoantibody, and
repletes ADAMTS13.
23. The prospect of a future pregnancy…
Women with previous history who wish to conceive should
be counseled and closely monitored for platelet count,
hemoglobin, LDH and peripheral smear throughout the
course of pregnancy.
Plasma therapy should be stared at the earliest evidence of
a relapse of TTP.
Prophylactic plasma infusion in a pregnant woman with a
history relapsing TTP may be considered.
No association of TTP in subsequent pregnancies in
women presenting with TTP in an earlier pregnancy can be
made. Thus assurance is required foranxious women.